SCHEMBL15034407

SCHEMBL15034407

CC(C)c1ccccc1OPOc1ccccc1C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 1/20 0.45
P2RX2 Q9UBL9 1/20 0.45
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 2/20 0.40
NISCH Q9Y2I1 2/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 1/20 0.40
RECQL P46063 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
SLC6A2 P23975 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
FAAH O00519 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13536324 0.79 TSHR (0.52) GABRA1GABRB2NISCHKMT2AL3MBTL1
SCHEMBL9130041 0.78 GABRA1 (0.48) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL29959656 0.78 P2RX3 (0.58) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL4575432 0.78 P2RX3 (0.58) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL141647 0.78 CA1 (0.60) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL31257131 0.78 CA1 (0.60) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL10831082 0.77 TSHR (0.36) NISCHMEN1KMT2AL3MBTL1TSHR
Ammonia Solution, Strong SCHEMBL28077841 0.76 CA1 (0.57) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL9697299 0.76 P2RX3 (0.44) P2RX3P2RX2GABRA1GABRB2CYP1A2
SCHEMBL8245039 0.74 NISCH (0.49) P2RX3P2RX2GABRA1GABRB2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889805-B2 Carboxylate metal complex and catalyst for olefin polymerization SHOWA DENKO K.K. (JP) 2014-11-18 US disclosed
US-8889805-B2 Carboxylate metal complex and catalyst for olefin polymerization SHOWA DENKO K.K. (JP) 2014-11-18 US disclosed
US-20130158223-A1 CARBOXYLATE METAL COMPLEX AND CATALYST FOR OLEFIN POLYMERIZATION THE UNIVERSITY OF TOKYO (JP) 2013-06-20 US disclosed
US-20130158223-A1 CARBOXYLATE METAL COMPLEX AND CATALYST FOR OLEFIN POLYMERIZATION THE UNIVERSITY OF TOKYO (JP) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158223-A1 CARBOXYLATE METAL COMPLEX AND CATALYST FOR OLEFIN POLYMERIZATION ODC1, AOC2, SCO2 P2RX3 4877/4885P2RX2 4866/4885GABRA1 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.